165 related articles for article (PubMed ID: 27880061)
1. The safety profile of monoclonal antibodies for chronic lymphocytic leukemia.
Korycka-Wołowiec A; Wołowiec D; Robak T
Expert Opin Drug Saf; 2017 Feb; 16(2):185-201. PubMed ID: 27880061
[TBL] [Abstract][Full Text] [Related]
2. Ofatumumab for treating chronic lymphocytic leukemia: a safety profile.
Korycka-Wołowiec A; Wołowiec D; Robak T
Expert Opin Drug Saf; 2015; 14(12):1945-59. PubMed ID: 26566719
[TBL] [Abstract][Full Text] [Related]
3. Ofatumumab: a novel anti-CD20 monoclonal antibody for treatment of refractory chronic lymphocytic leukemia.
Nightingale G
Ann Pharmacother; 2011 Oct; 45(10):1248-55. PubMed ID: 21896924
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for chronic lymphocytic leukemia.
Robak T
Expert Opin Biol Ther; 2012 Apr; 12(4):503-15. PubMed ID: 22369284
[TBL] [Abstract][Full Text] [Related]
5. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
6. Emerging immunological drugs for chronic lymphocytic leukemia.
Robak P; Smolewski P; Robak T
Expert Opin Emerg Drugs; 2015 Sep; 20(3):423-47. PubMed ID: 26153226
[TBL] [Abstract][Full Text] [Related]
7. Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.
Reagan JL; Castillo JJ
Expert Rev Anticancer Ther; 2011 Feb; 11(2):151-60. PubMed ID: 21342032
[TBL] [Abstract][Full Text] [Related]
8. Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia.
Reagan JL; Castillo JJ
Future Oncol; 2014 May; 10(7):1147-55. PubMed ID: 24947256
[TBL] [Abstract][Full Text] [Related]
9. Current status of monoclonal antibody therapy for chronic lymphocytic leukemia.
Nabhan C; Dyer MJ; Rosen ST
Oncology (Williston Park); 2003 Feb; 17(2):253-62; discussion 264, 267, passim. PubMed ID: 12632866
[TBL] [Abstract][Full Text] [Related]
10. The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia.
Evers M; Jak M; Leusen JHW
Expert Opin Biol Ther; 2018 Sep; 18(9):973-982. PubMed ID: 30084674
[TBL] [Abstract][Full Text] [Related]
11. Ofatumumab for the treatment of chronic lymphocytic leukemia.
Grosicki S
Expert Rev Hematol; 2015 Jun; 8(3):265-72. PubMed ID: 25882470
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in chronic lymphocytic leukemia.
Jaglowski SM; Byrd JC
Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
[TBL] [Abstract][Full Text] [Related]
13. Ofatumumab (Arzerra) for CLL.
Med Lett Drugs Ther; 2010 Jun; 52(1341):51-2. PubMed ID: 20585286
[No Abstract] [Full Text] [Related]
14. Improving treatment for patients with chronic lymphocytic leukemia.
Shanafelt TD
Hematology; 2012 Apr; 17 Suppl 1():S133-6. PubMed ID: 22507801
[TBL] [Abstract][Full Text] [Related]
15. Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
Robak T; Blonski JZ; Robak P
Semin Oncol; 2016 Apr; 43(2):280-90. PubMed ID: 27040707
[TBL] [Abstract][Full Text] [Related]
16. Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events.
Chanan-Khan A; Kipps T; Stilgenbauer S
Clin Adv Hematol Oncol; 2010 Aug; 8(8):suppl 1-15. PubMed ID: 21192630
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL.
Klepfish A; Gilles L; Ioannis K; Rachmilewitz EA; Schattner A
Ann N Y Acad Sci; 2009 Sep; 1173():865-73. PubMed ID: 19758239
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody therapy of chronic lymphocytic leukemia.
Mavromatis B; Cheson BD
J Clin Oncol; 2003 May; 21(9):1874-81. PubMed ID: 12721266
[TBL] [Abstract][Full Text] [Related]
20. New treatment options for chronic lymphocytic leukemia.
Delgado J; Baumann T; Santacruz R; Montserrat E
Expert Opin Pharmacother; 2014 Apr; 15(6):823-32. PubMed ID: 24559127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
